Serial Number | 88317403 |
Word Mark | ELEV8BIO |
Filing Date | Tuesday, February 26, 2019 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, November 18, 2019 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | NOT AVAILABLE |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Description of Mark | The mark consists of The letters ELEV, followed by a stylized 8, followed by the letters BIO. |
Goods and Services | Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Business development services, namely, marketing strategy development and implementation of strategy plans; Personnel management services in the nature of advisory board development and management; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies |
Goods and Services | Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
Pseudo Mark | ELEVATE BIO |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, March 18, 2019 |
Primary Code | 035 |
First Use Anywhere Date | Friday, September 1, 2017 |
First Use In Commerce Date | Friday, September 1, 2017 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, March 18, 2019 |
Primary Code | 042 |
First Use Anywhere Date | Friday, September 1, 2017 |
First Use In Commerce Date | Friday, September 1, 2017 |
Party Name | Elev8Bio LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Seattle, WA 98115 |
Event Date | Event Description |
Monday, November 18, 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, November 18, 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Tuesday, May 7, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, May 7, 2019 | NON-FINAL ACTION E-MAILED |
Tuesday, May 7, 2019 | NON-FINAL ACTION WRITTEN |
Tuesday, May 7, 2019 | ASSIGNED TO EXAMINER |
Monday, March 18, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Friday, March 1, 2019 | NEW APPLICATION ENTERED IN TRAM |